ProCyte Corporation (OTCBB:PRCY) is a publicly-held healthcare company that is committed to bringing innovation and experience to skin health and wound care market professionals through products that contain its patented GHK and AHK copper peptide technologies.
ProCyte's copper peptide technologies utilize a sequence of amino acid carriers for health-essential copper. This unique delivery system mimics the body's natural copper transport mechanisms and has a variety of applications in skin health, tissue repair and hair care. ProCyte holds over 100 issued patents and patent registrations worldwide on its proprietary copper-based technology.
ProCyte markets its products directly to plastic surgeons and dermatologists through its direct sales force and through distributors for the International markets. In addition, there are significant consumer market opportunities, which will be addressed primarily through license agreements with strong partners in each market segment.
Current licensing agreements include partnerships with Neutrogena (a Johnson and Johnson Company) for use in their Visibly FirmTM line of skin care products and American Crew (a division of The Colomer Group) for use in men抯 salon, hair care line.
Located in Redmond, Washington, the Company's scientific team continues its pursuit of new technology and excellence, quickly bringing new products to the marketplace that address healthcare and physician needs.
Healing the Wounds of Time, Neova, Tricomin, Complex Cu3, Ti-Silc, Z-Silc, Iamin, OsmoCyte, NextDerm, PilloPro, and Humaceuticals are all registered trademarks of ProCyte Corporation. GraftCyte and GHK Copper Peptide Complex are trademarks of ProCyte Corporation.
Search Product